William J Muller

Grants

Grants per year 2007 2015 2017 2018 2019 2050

• 23 Active
• 47 Finished

Grants per year

Search results

• Active

  Gilead GS-US-540-5823: A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Remdesivir (GS-5734?) in Participants from Birth to < 18 Years of Age with COVID-19

  Muller, W. J. (PD/PI)

  Gilead Sciences, Inc

  7/15/20 → 8/31/50

  Project: Research project

• NAB-BC-3781-1202: A Phase 1, Open-Label, Two-Part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Intravenous Lefamulin in Hospitalized Pediatric Subjects Receiving Standard of Care Antibiotic Therapy for Confirmed or

  Muller, W. J. (PD/PI)

  Nabriva Therapeutics Ireland DAC

  6/11/20 → 8/31/50

  Project: Research project

• Clinical Comparison of the BD FecalSwab Collection, Transport and Preservation System to the Cary-Blair Specimen or the Unpreserved Specimen on the BD MAX Enteric Assays

  Muller, W. J. (PD/PI)

  Becton, Dickinson and Company

  2/25/20 → 8/31/50

  Project: Research project

• A Phase 2, Open-Label, Non-Comparative Clinical Trial to Study the Safety and Efficacy of Posaconazole (POS, MK-5592) in Pediatric Participants Aged 2 to <18 Years With Invasive Aspergillosis

  Muller, W. J. (PD/PI)

  Merck Sharp & Dohme Corp

  2/3/20 → 8/31/50

  Project: Research project

• Consultation of Influenza Trial Design for Immuno-Compromised Pediatric Subjects

  Muller, W. J. (PD/PI)

  Seqirus Inc.

  11/22/19 → 8/31/50

  Project: Research project

• A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

  Muller, W. J. (PD/PI)

  MedImmune, Inc.

  10/25/19 → 8/31/50

  Project: Research project

• A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)

  Muller, W. J. (PD/PI)

  MedImmune, Inc.

  10/25/19 → 8/31/50

  Project: Research project

• DAS181-3-01: A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

  Muller, W. J. (PD/PI)

  Ansun Biopharma, Inc.

  6/20/19 → 8/31/50

  Project: Research project

• A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Subject

  Muller, W. J. (PD/PI)

  Astellas Pharma US, Inc

  3/19/19 → 8/31/50

  Project: Research project

• Protocol 63623872FLZ3002; Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and El

  Muller, W. J. (PD/PI)

  Janssen Research & Development, LLC

  3/18/19 → 8/31/50

  Project: Research project

• CP40559: A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF BALOXAVIR MARBOXIL IN OTHERWISE HEALTHYPEDIATRIC PATIENTS FROM BIRTH TO 1 YEAR WITH INFLUENZA-LIKE SYMPTOMS

  Muller, W. J. (PD/PI)

  Genentech, Inc

  3/11/19 → 8/31/50

  Project: Research project

• A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses of JNJ-53718678 in Children ?28 Days

  Muller, W. J. (PD/PI)

  Janssen Research & Development, LLC

  2/22/19 → 8/31/50

  Project: Research project

• Protocol# 1832301: Collection of Dual Throat Swabs for the detection of Group A Streptococcus (PPR, CTA SOW 9)

  Muller, W. J. (PD/PI)

  Abbott Laboratories

  1/25/19 → 12/31/50

  Project: Research project

• Protocol# 1832301: Collection of Dual Throat Swabs for the detection of Group A Streptococcus (MSA Laboratory - SOW)

  Muller, W. J. (PD/PI)

  Alere Scarborough, Inc., Abbott Laboratories

  1/25/19 → 12/31/50

  Project: Research project

• Alere 1822001: Evaluation of the Clinical Performance of the Modified AlereTM Influenza A & B Test

  Muller, W. J. (PD/PI)

  Alere Scarborough, Inc.

  11/20/18 → 8/31/50

  Project: Research project

• MK1986-014-1022: A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV TedizolidPhosphate (MK-1986) in Inpatients Under 2 Years Old

  Muller, W. J. (PD/PI)

  Merck Sharp & Dohme Corp

  11/20/18 → 8/31/50

  Project: Research project

• TP-434-028: A PHASE 1, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PHARMACOKINETICS AND SAFETY OF INTRAVENOUS ERAVACYCLINE IN CHILDREN WITH SUSPECTED OR CONFIRMED BACTERIAL INFECTION

  Muller, W. J. (PD/PI)

  Tetraphase Pharmaceuticals, Inc.

  10/31/18 → 10/30/50

  Project: Research project

• MK-7625A-034: Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjects with Complic

  Muller, W. J. (PD/PI)

  Merck Sharp & Dohme Corp

  10/11/18 → 8/31/50

  Project: Research project

• MK-1986-018 - A Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Subjects from Birth to <12 Years of Age with Acute Bacterial

  Muller, W. J. (PD/PI)

  Merck Sharp & Dohme Corp

  8/1/18 → 8/31/50

  Project: Research project

• REMPEX-507 Tango Kids: An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects from Birth to Less Than 18 Years of Age with....

  Muller, W. J. (PD/PI)

  Rempex Pharmaceuticals, Inc.

  7/9/18 → 8/31/50

  Project: Research project

• Protocol ISN: 9766-MA-3034 - Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles

  Muller, W. J. (PD/PI)

  Astellas Pharma US, Inc

  12/31/17 → 8/31/50

  Project: Research project

• Clinical Trials Units for NIAID Networks, HIV Centers for Underrepresented Populations in Research (HIV CURE) CTU

  Chadwick, E. (PD/PI), Muller, W. J. (PD/PI) & Simons, L. K. (PD/PI)

  University of California at San Diego, National Institute of Allergy and Infectious Diseases

  12/1/17 → 11/30/27

  Project: Research project

• An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease (CMX001-351)

  Muller, W. J. (PD/PI)

  Chimerix, Inc.

  9/1/16 → 8/31/50

  Project: Research project